EpiCareSRT’s mobile services application of the Sensus SRT-100 system, utilizing proprietary mobile x-ray technology provides a new option for dermatologists to treat basal cell and squamous cell carcinomas on an out-patient basis.
The SRT-100 delivers high cure-low recurrence rates, no scarring and the convenience of treatment at the doctor’s office.
EpiCareSRT CEO Dale Ranney said the solution improves the quality of care for the patient while increasing the value of the dermatologist’s practice.
Sensus Healthcare VP of Strategic Initiatives Steve Cohen said offering additional treatment options to patients will help dermatologists give more treatment choices to their patients, retain their patient base and thereby increase revenues.
